71
Views
1
CrossRef citations to date
0
Altmetric
Review

Recent epidemiology of neonatal sepsis in Japan: did the strategies to control and prevent MRSA transmission lead to a reduction in the incidence of late-onset sepsis?

, , , , , , , & show all
Pages 177-181 | Published online: 21 Oct 2014

References

  • Hornik CP, Fort P, Clark RH, et al. Early and late onset sepsis in very-low-birth-weight infants from a large group of neonatal intensive care units. Early Hum Dev. 2012;88 Suppl 2:S69–S74.
  • Lawn JE, Wilczynska-Ketende K, Cousens SN. Estimating the causes of 4 million neonatal deaths in the year 2000. Int J Epidemiol. 2006;35(3):706–718.
  • Sankar MJ, Agarwal R, Deorari AK, Paul VK. Sepsis in the newborn. Indian J Pediatr. 2008;75(3):261–266.
  • Satar M, Ozlü F. Neonatal sepsis: a continuing disease burden. Turk J Pediatr. 2012;54(5):449–457.
  • Morioka I, Morikawa S, Miwa A, et al. Culture-proven neonatal sepsis in Japanese neonatal care units in 2006–2008. Neonatology. 2012;102(1):75–80.
  • Shane AL, Stoll BJ. Recent developments and current issues in the epidemiology, diagnosis, and management of bacterial and fungal neonatal sepsis. Am J Perinatol. 2013;30(2):131–141.
  • Gardner SL. Sepsis in the neonate. Crit Care Nurs Clin North Am. 2009;21(1):121–141, vii.
  • Wynn JL, Levy O. Role of innate host defenses in susceptibility to early-onset neonatal sepsis. Clin Perinatol. 2010;37(2):307–337.
  • Stoll BJ, Hansen NI, Adams-Chapman I, et al; National Institute of Child Health and Human Development Neonatal Research Network. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA. 2004;292(19):2357–2365.
  • Shah DK, Doyle LW, Anderson PJ, et al. Adverse neurodevelopment in preterm infants with postnatal sepsis or necrotizing enterocolitis is mediated by white matter abnormalities on magnetic resonance imaging at term. J Pediatr. 2008;153(2):170–175, 175. e1.
  • Volpe JJ. Postnatal sepsis, necrotizing entercolitis, and the critical role of systemic inflammation in white matter injury in premature infants. J Pediatr. 2008;153(2):160–163.
  • Bizzarro MJ, Raskind C, Baltimore RS, Gallagher PG. Seventy-five years of neonatal sepsis at Yale: 1928–2003. Pediatrics. 2005;116(3):595–602.
  • Vergnano S, Sharland M, Kazembe P, Mwansambo C, Heath PT. Neonatal sepsis: an international perspective. Arch Dis Child Fetal Neonatal Ed. 2005;90(3):F220–F224.
  • Baltimore RS. Neonatal sepsis: epidemiology and management. Paediatr Drugs. 2003;5(11):723–740.
  • Usukura Y, Igarashi T. Examination of severe, hospital acquired infections affecting extremely low birthweight (ELBW) infants. Pediatr Int. 2003;45(2):230–232.
  • Morioka I, Takahashi N, Kitajima H; Committee for Infection Prevention and Vaccine Promotion of the Japan Society for Premature and Newborn Medicine. Prevalence of MRSA colonization in Japanese neonatal care unit patients in 2011. Pediatr Int. 2014;56(2):211–214.
  • Mulligan ME, Murray-Leisure KA, Ribner BS, et al. Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med. 1993;94(3):313–328.
  • Kitajima H. Prevention of methicillin-resistant Staphylococcus aureus infections in neonates. Pediatr Int. 2003;45(2):238–245.
  • Strausbaugh LJ, Siegel JD, Weinstein RA. Preventing transmission of multidrug-resistant bacteria in health care settings: a tale of 2 guidelines. Clin Infect Dis. 2006;42(6):828–835.
  • Vergnano S, Menson E, Kennea N, et al. Neonatal infections in England: the NeonIN surveillance network. Arch Dis Child Fetal Neonatal Ed. 2011;96(1):F9–F14.
  • Stoll BJ, Hansen NI, Sánchez PJ, et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics. 2011;127(5):817–826.
  • Matsubara K, Hoshina K, Suzuki Y. Early-onset and late-onset group B streptococcal disease in Japan: a nationwide surveillance study, 2004–2010. Int J Infect Dis. 2013;17(6):e379–e384.
  • Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep. 2002;51(RR-11):1–22.
  • Kusuda S, Fujimura M, Sakuma I, et al; Neonatal Research Network, Japan. Morbidity and mortality of infants with very low birth weight in Japan: center variation. Pediatrics. 2006;118(4):e1130–e1138.
  • Isayama T, Lee SK, Mori R, et al; Canadian Neonatal Network; Neonatal Research Network of Japan. Comparison of mortality and morbidity of very low birth weight infants between Canada and Japan. Pediatrics. 2012;130(4):e957–e965.
  • Boghossian NS, Page GP, Bell EF, et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Late-onset sepsis in very low birth weight infants from singleton and multiple-gestation births. J Pediatr. 2013;162(6):1120–1124, 1124. e1.
  • Wu JH, Chen CY, Tsao PN, Hsieh WS, Chou HC. Neonatal sepsis: a 6-year analysis in a neonatal care unit in Taiwan. Pediatr Neonatol. 2009;50(3):88–95.
  • Itabashi K, Horiuchi T, Kusuda S, et al. Mortality rates for extremely low birth weight infants born in Japan in 2005. Pediatrics. 2009;123(2):445–450.
  • Boyce JM, Pittet D; Healthcare Infection Control Practices Advisory Committee; HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America. MMWR Recomm Rep. 2002;51(RR–16):1–45, quiz CE1–4.
  • Siegel JD, Rhinehart E, Jackson M, Chiarello L; Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007;35(10 Suppl 2):S165–S193.